568 related articles for article (PubMed ID: 33147457)
21. The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.
Kovar H; Amatruda J; Brunet E; Burdach S; Cidre-Aranaz F; de Alava E; Dirksen U; van der Ent W; Grohar P; Grünewald TG; Helman L; Houghton P; Iljin K; Korsching E; Ladanyi M; Lawlor E; Lessnick S; Ludwig J; Meltzer P; Metzler M; Mora J; Moriggl R; Nakamura T; Papamarkou T; Radic Sarikas B; Rédini F; Richter GH; Rossig C; Schadler K; Schäfer BW; Scotlandi K; Sheffield NC; Shelat A; Snaar-Jagalska E; Sorensen P; Stegmaier K; Stewart E; Sweet-Cordero A; Szuhai K; Tirado OM; Tirode F; Toretsky J; Tsafou K; Üren A; Zinovyev A; Delattre O
Oncotarget; 2016 Feb; 7(8):8613-24. PubMed ID: 26802024
[TBL] [Abstract][Full Text] [Related]
22. PRAS40 is a functionally critical target for EWS repression in Ewing sarcoma.
Huang L; Nakai Y; Kuwahara I; Matsumoto K
Cancer Res; 2012 Mar; 72(5):1260-9. PubMed ID: 22241085
[TBL] [Abstract][Full Text] [Related]
23. Exosomes from CD99-deprived Ewing sarcoma cells reverse tumor malignancy by inhibiting cell migration and promoting neural differentiation.
De Feo A; Sciandra M; Ferracin M; Felicetti F; Astolfi A; Pignochino Y; Picci P; Carè A; Scotlandi K
Cell Death Dis; 2019 Jun; 10(7):471. PubMed ID: 31209202
[TBL] [Abstract][Full Text] [Related]
24. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
[TBL] [Abstract][Full Text] [Related]
25. MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4 oncogene to inhibit anchorage-independent growth.
Moore C; Parrish JK; Jedlicka P
PLoS One; 2017; 12(5):e0178028. PubMed ID: 28542597
[TBL] [Abstract][Full Text] [Related]
26. PI3K/AKT signaling modulates transcriptional expression of EWS/FLI1 through specificity protein 1.
Giorgi C; Boro A; Rechfeld F; Lopez-Garcia LA; Gierisch ME; Schäfer BW; Niggli FK
Oncotarget; 2015 Oct; 6(30):28895-910. PubMed ID: 26336820
[TBL] [Abstract][Full Text] [Related]
27. EWS-FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma.
Gorthi A; Romero JC; Loranc E; Cao L; Lawrence LA; Goodale E; Iniguez AB; Bernard X; Masamsetti VP; Roston S; Lawlor ER; Toretsky JA; Stegmaier K; Lessnick SL; Chen Y; Bishop AJR
Nature; 2018 Mar; 555(7696):387-391. PubMed ID: 29513652
[TBL] [Abstract][Full Text] [Related]
28. Epigenome editing of microsatellite repeats defines tumor-specific enhancer functions and dependencies.
Boulay G; Volorio A; Iyer S; Broye LC; Stamenkovic I; Riggi N; Rivera MN
Genes Dev; 2018 Aug; 32(15-16):1008-1019. PubMed ID: 30042132
[TBL] [Abstract][Full Text] [Related]
29. Targeting Histone Deacetylase Activity to Arrest Cell Growth and Promote Neural Differentiation in Ewing Sarcoma.
Souza BK; da Costa Lopez PL; Menegotto PR; Vieira IA; Kersting N; Abujamra AL; Brunetto AT; Brunetto AL; Gregianin L; de Farias CB; Thiele CJ; Roesler R
Mol Neurobiol; 2018 Sep; 55(9):7242-7258. PubMed ID: 29397557
[TBL] [Abstract][Full Text] [Related]
30. C/EBPβ-1 promotes transformation and chemoresistance in Ewing sarcoma cells.
Gardiner JD; Abegglen LM; Huang X; Carter BE; Schackmann EA; Stucki M; Paxton CN; Lor Randall R; Amatruda JF; Putnam AR; Kovar H; Lessnick SL; Schiffman JD
Oncotarget; 2017 Apr; 8(16):26013-26026. PubMed ID: 28148901
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of SOX2 induces cell apoptosis and G1/S arrest in Ewing's sarcoma through the PI3K/Akt pathway.
Ren C; Ren T; Yang K; Wang S; Bao X; Zhang F; Guo W
J Exp Clin Cancer Res; 2016 Mar; 35():44. PubMed ID: 26969300
[TBL] [Abstract][Full Text] [Related]
32. Synthetic siRNA targeting the breakpoint of EWS/Fli-1 inhibits growth of Ewing sarcoma xenografts in a mouse model.
Takigami I; Ohno T; Kitade Y; Hara A; Nagano A; Kawai G; Saitou M; Matsuhashi A; Yamada K; Shimizu K
Int J Cancer; 2011 Jan; 128(1):216-26. PubMed ID: 20648560
[TBL] [Abstract][Full Text] [Related]
33. LIN28B Underlies the Pathogenesis of a Subclass of Ewing Sarcoma LIN28B Control of EWS-FLI1 Stability.
Keskin T; Bakaric A; Waszyk P; Boulay G; Torsello M; Cornaz-Buros S; Chevalier N; Geiser T; Martin P; Volorio A; Iyer S; Kulkarni A; Letovanec I; Cherix S; Cote GM; Choy E; Digklia A; Montemurro M; Chebib I; Nielsen PG; Carcaboso AM; Mora J; Renella R; Suvà ML; Fusco C; Provero P; Rivera MN; Riggi N; Stamenkovic I
Cell Rep; 2020 Mar; 30(13):4567-4583.e5. PubMed ID: 32234488
[TBL] [Abstract][Full Text] [Related]
34. The role of miR-17-92 in the miRegulatory landscape of Ewing sarcoma.
Schwentner R; Herrero-Martin D; Kauer MO; Mutz CN; Katschnig AM; Sienski G; Alonso J; Aryee DN; Kovar H
Oncotarget; 2017 Feb; 8(7):10980-10993. PubMed ID: 28030800
[TBL] [Abstract][Full Text] [Related]
35. Clofarabine inhibits Ewing sarcoma growth through a novel molecular mechanism involving direct binding to CD99.
Çelik H; Sciandra M; Flashner B; Gelmez E; Kayraklıoğlu N; Allegakoen DV; Petro JR; Conn EJ; Hour S; Han J; Oktay L; Tiwari PB; Hayran M; Harris BT; Manara MC; Toretsky JA; Scotlandi K; Üren A
Oncogene; 2018 Apr; 37(16):2181-2196. PubMed ID: 29382926
[TBL] [Abstract][Full Text] [Related]
36. CD99 triggering induces methuosis of Ewing sarcoma cells through IGF-1R/RAS/Rac1 signaling.
Manara MC; Terracciano M; Mancarella C; Sciandra M; Guerzoni C; Pasello M; Grilli A; Zini N; Picci P; Colombo MP; Morrione A; Scotlandi K
Oncotarget; 2016 Nov; 7(48):79925-79942. PubMed ID: 27835596
[TBL] [Abstract][Full Text] [Related]
37. Olfactory neuroblastoma is not related to the Ewing family of tumors: absence of EWS/FLI1 gene fusion and MIC2 expression.
Argani P; Perez-Ordoñez B; Xiao H; Caruana SM; Huvos AG; Ladanyi M
Am J Surg Pathol; 1998 Apr; 22(4):391-8. PubMed ID: 9580174
[TBL] [Abstract][Full Text] [Related]
38. EWS-FLI1 confers exquisite sensitivity to NAMPT inhibition in Ewing sarcoma cells.
Mutz CN; Schwentner R; Aryee DNT; Bouchard EDJ; Mejia EM; Hatch GM; Kauer MO; Katschnig AM; Ban J; Garten A; Alonso J; Banerji V; Kovar H
Oncotarget; 2017 Apr; 8(15):24679-24693. PubMed ID: 28160567
[TBL] [Abstract][Full Text] [Related]
39. Meningeal Ewing Sarcoma/Peripheral PNET: Clinicopathological, Immunohistochemical and FISH study of four cases.
Ke Ch; Duan Q; Yang H; Zhu F; Yan M; Xu SP; Zhou S; Wan F; Shu K; Lei T; Xia LM
Neuropathology; 2017 Feb; 37(1):35-44. PubMed ID: 27500883
[TBL] [Abstract][Full Text] [Related]
40. Imatinib revives the therapeutic potential of metformin on ewing sarcoma by attenuating tumor hypoxic response and inhibiting convergent signaling pathways.
Nan X; Wang J; Cheng H; Yin Z; Sheng J; Qiu B; Lau CC; Yustein JT; Zhao H; Wong STC
Cancer Lett; 2020 Jan; 469():195-206. PubMed ID: 31672491
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]